CJC-1295 +Ipamorelin
A Targeted Approach to Hormonal Optimization and Recovery
1,000 + Patients Served
24 /7 Telehealth Access
15 + Treatments Available
98 % Patient Satisfaction
Overview
CJC-1295 and Ipamorelin are peptides that work synergistically to support the body’s natural growth hormone (GH) production. This combination is used in wellness and regenerative settings to promote physiologic GH pulsatility while minimizing unwanted hormonal fluctuations.
Potential Clinical Applications
Sleep quality and recovery enhancement
Body composition optimization (lean mass support, fat metabolism)
Support for recovery and physical performance
Adjunctive support in age-related decline in GH signaling
Energy, vitality, and overall wellness support
Clinical Rationale
This combination targets key pathways involved in:
Support of IGF-1 production and downstream anabolic activity
Stimulation of endogenous growth hormone release (pituitary signaling)
Metabolic regulation and recovery processes
Preservation of physiologic GH pulsatility patterns
Together, these mechanisms contribute to improved recovery, body composition, and overall physiologic resilience.
Administration
Typically administered via subcutaneous injection, often in the evening to align with natural GH secretion patterns. Protocols are individualized based on clinical goals and response.
Sample Dosing Protocol (Example Only): 375 mcg administered by subcutaneous injection once daily in the evening.
Wellness & Regenerative Focus
This therapy is part of a broader strategy aimed at optimizing hormonal balance, enhancing recovery capacity, and supporting healthy aging through physiologic pathways.
This information is provided for educational purposes and reflects a general overview of studied biologic mechanisms. Statements have not been evaluated by the FDA. Individual protocols, appropriateness, and outcomes are determined on a case-by-case basis following clinical evaluation. Individual results may vary.